Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia
Conditions: Laryngomalacia; Gastro Esophageal Reflux Interventions: Drug: Famotidine; Other: Speech Language Therapy Sponsor: Reema Padia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 4, 2020 Category: Research Source Type: clinical trials
Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia
Conditions: Laryngomalacia; Gastro Esophageal Reflux Interventions: Drug: Famotidine; Other: Speech Language Therapy Sponsor: Reema Padia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 4, 2020 Category: Research Source Type: clinical trials
The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial
This study aims to investigate the effect of Famotidine on the recovery process of COVID-19 patients.Trial designThis phase III randomized clinical trial was designed with two parallel arms, placebo-controlled, single-blind, and concealed allocation.ParticipantsAll COVID-19 patients admitted to Shahid Mohammadi Hospital in Bandar Abbas whose PCR test results are positive for SARS-Cov-2 and sign the written consent of the study are included in the study and immunocompromised patients, end-stage renal disease, moderate renal failure (clearance Creatinine 30 to 50 ml/min) or stage 4 severe chronic kidney disease or need for d...
Source: Trials - October 13, 2020 Category: Research Source Type: clinical trials
